These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33585037)

  • 1. Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings.
    Lau JS; Rasmussen TA; Lewin SR; Ehm A; Martinez C; Burnett C; McMahon JH
    J Virus Erad; 2021 Mar; 7(1):100032. PubMed ID: 33585037
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations.
    Garner SA; Rennie S; Ananworanich J; Dube K; Margolis DM; Sugarman J; Tressler R; Gilbertson A; Dawson L
    J Virus Erad; 2017 Apr; 3(2):82-84. PubMed ID: 28435691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mother-to-child transmission of HIV infection.
    Thorne C; Newell ML
    Curr Opin Infect Dis; 2004 Jun; 17(3):247-52. PubMed ID: 15166829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy and mother-to-child transmission of HIV-1.
    Newell ML; Thorne C
    Expert Rev Anti Infect Ther; 2004 Oct; 2(5):717-32. PubMed ID: 15482235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials.
    Gaillard P; Fowler MG; Dabis F; Coovadia H; Van Der Horst C; Van Rompay K; Ruff A; Taha T; Thomas T; De Vincenzi I; Newell ML;
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):178-87. PubMed ID: 14722452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of HIV infection in pregnant women: antiretroviral management options.
    Loutfy MR; Walmsley SL
    Drugs; 2004; 64(5):471-88. PubMed ID: 14977385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.
    Chou R; Cantor AG; Zakher B; Bougatsos C
    Ann Intern Med; 2012 Nov; 157(10):719-28. PubMed ID: 23165663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment interruption research: the trial most needed now.
    Scondras D
    AIDS Treat News; 1999 Jun; (No 320):3. PubMed ID: 11366466
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.